ZAHIDAH NASUHA MOHD YASIN

Ms. ZAHIDAH NASUHA MOHD YASIN

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Differentiation
Verified
Journal Article
Closed access
ZYZAHIDAH NASUHA MOHD YASIN
ZAHIDAH NASUHA MOHD YASIN
FIFatin Najiah Mohd Idrus
Fatin Najiah Mohd Idrus
CHChee Hock Hoe
Chee Hock Hoe
YBYvonne-Tee Get Bee
Yvonne-Tee Get Bee

26 December 2025 in Immuno
Verified
Journal Article
Open access
PDF file
FIFatin Najiah Mohd Idrus
Fatin Najiah Mohd Idrus
HAHayat Asaad Hameed Al-Ali
Hayat Asaad Hameed Al-Ali
ZYZAHIDAH NASUHA MOHD YASIN
ZAHIDAH NASUHA MOHD YASIN
MARYAM AZLANMARYAM AZLAN
MARYAM AZLAN
RSRapeah Suppain
Rapeah Suppain
YBYvonne-Tee Get Bee
Yvonne-Tee Get Bee
Efferocytosis, the process by which macrophages clear apoptotic cells, plays a vital role in maintaining immune homeostasis. This study explores the influence of inflammatory cytokines—tumor necrosis factor-alpha (TNF-α) and transforming growth factor-beta (TGF-β)—on efferocytosis dysregulation in coronary artery disease (CAD). Peripheral blood samples were collected from 27 non-obstructive and 29 obstructive CAD patients to isolate monocytes, which were then differentiated into M1 and M2 macrophages using specific cytokine stimuli. These macrophages were transfected with TNF-α and TGF-β siRNA to assess cytokine impact on efferocytosis. Expression levels of the efferocytosis receptor MERTK and its regulatory protease ADAM17 were quantified via qPCR. Statistical analysis revealed significantly higher MERTK expression in M2 macrophages compared to M1 (p = 0.002). Notably, TNF-α silencing enhanced efferocytosis in M2 macrophages, with increased clearance of early apoptotic bodies in non-obstructive CAD and late apoptotic bodies in obstructive CAD (both p < 0.001). These findings suggest that macrophage phenotype, apoptotic stage, and cytokine environment influence efferocytosis efficiency and may involve pathways beyond MERTK-ADAM17. They offer preliminary mechanistic insights into cytokine-mediated modulation of efferocytosis in CAD. Further in vivo studies are needed to confirm these observations and evaluate their relevance for future therapeutic strategies.